We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 15 investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Novus aspires to become the UK's first ethical digital bank. It argues that Generation Z and millennials want purpose-driven products and services that can also address environmental and social challenges of the times. The company asserts that its services align with the aforementioned objective. Novus allows its members to live a sustainable lifestyle by providing them access to sustainable brands through Novus' in-app marketplace and rewarding them via cashbacks. The company intends to undergo two more funding rounds – Series A and Series B – for scaling its UK operations and expanding in the US and other key EU markets within the next two years. It will IPO its business when it achieves profitability. The company also foresees a strategic exit to interested banking entities.
days to go: Expired investment: £732,000
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go: Expired investment: £3,768,260
PayRue is a London based cryptocurrency wallet. It offers an application that enables people to exchange, store, and transfer cryptocurrency in a hassle freeway. PayRue has grown its user base over 22k registered users. Its application is live on Android, Web app, and iOS. PayRue is regulated for Digital Wallet services and Crypto exchange. It is offering exchange services of ETH, BTC, Propel, XLM, and USDC. The company is planning to allocate 40% of the invested funds for product development, 40% for marketing and 20% for admin.
days to go: Expired investment: £118,098
Plug-N-Go is a company that provides electric vehicle charging infrastructure with the aim of sustainably electrifying transport. The company has 24 charge points that are accessible to users via its app. It sources 100% renewable energy from its partners at Octopus Energy. Air pollution is contributing to 40,000 early deaths a year in the UK that Plug-N-Go is striving to change. The global electric vehicle charging stations market will reach USD 27.7 billion by 2027 from an estimated USD 2.5 billion in 2019. The company hopes to become a strong contender in this segment. Plug-N-Go is in discussions over multi-site agreements with the Co-operative Society and Eden district council and has received interest from Associated British Ports. Its goal is to install 3,800 EV charge points for the public in 5 years at sites where drivers are already parking. The company will use the investment to deliver EV charging stations to businesses across the UK.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £176,008
WeTRAIN is a new way to have fun with personal training. They are the first shared personal training company and by doing this, they are creating a market of social exercise. WeTRAIN makes it easy for friends to have high quality, personalised training in a variety of different classes.
days to go: Expired investment: £437,138
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph